Intrexon Corporation (NYSE:XON) announced it will release first half and second quarter 2015 financial results after the market closes on Monday, August 10th, 2015. The Company will host a conference call at 5:30 PM ET to discuss the results and provide a general business update. Intrexon Corporation (NYSE:XON) belongs to Healthcare sector. Its net profit margin is -60.20% and weekly performance is 3.36%. On last trading day company shares ended up $65.55. Intrexon Corporation (NYSE:XON) distance from 50-day simple moving average (SMA50) is 29.48%.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) reported a non-GAAP net loss of $35.9 million, or $0.87 per share, compared to a non-GAAP net loss of $24.5 million for the second quarter of 2014, or $0.61 per share. The incremental loss of $11.4 million was primarily the result of increased operating expenses as well as a decrease in revenue from the Company’s government contracts. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares advanced 5.81% in last trading session and ended the day at $34.63. SRPT return on assets is -56.60%. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) quarterly performance is 130.25%.
Insmed Incorporated (NASDAQ:INSM) posted a net loss of $28.6 million, or ($0.47) per share, compared with a net loss of $23.2 million, or ($0.59) per share, for the second quarter of 2014. Research and development expenses were $18.2 million for the second quarter of 2015, compared with $14.9 million for the second quarter of 2014. The increase was primarily due to the advancement of the company’s global phase 3 CONVERT study of ARIKAYCE in NTM lung disease.On 06 August, Insmed Incorporated (NASDAQ:INSM) shares moved down -2.87% and was closed at $26.75. INSM EPS growth in last 5 year was -17.10%. Insmed Incorporated (NASDAQ:INSM) year to date (YTD) performance is 72.92%.
Emergent BioSolutions, Inc. (NYSE:EBS) announced on Thursday that it intends to spin off a portion of the company into a separate publicly traded company. This would create two independent companies that will have different growth strategies and operational and developmental priorities. Emergent BioSolutions, Inc. (NYSE:EBS) ended the last trading day at $34.60. Company weekly volatility is calculated as 3.19% and price to cash ratio as 6.13. Emergent BioSolutions, Inc. (NYSE:EBS) showed a weekly performance of 5.62%.
Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2015. The quarterly dividend will be payable August 28, 2015 to all common shareholders of record on August 17, 2015. Future cash dividends will be considered by the Board of Directors on a quarterly basis.Bio-Techne Corp. (NASDAQ:TECH) shares moved down -1.02% in last trading session and ended the day at $109.93. TECH Gross Margin is 68.30% and its return on assets is 10.50%. Bio-Techne Corp. (NASDAQ:TECH) quarterly performance is 12.78%.